Medicare Enrolled

Dr. Diana Echeverry-Franck, MD

Endocrinology · Long Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3610 LONG BEACH BLVD STE 101, Long Beach, CA 90807
5626349802
In practice since 2007 (19 years)
NPI: 1306981196 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Echeverry-Franck from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Echeverry-Franck? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Echeverry-Franck

Dr. Diana Echeverry-Franck is an endocrinology specialist in Long Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Echeverry-Franck performed 1,890 Medicare services across 981 unique beneficiaries.

Between the years covered by Open Payments, Dr. Echeverry-Franck received a total of $11,272 from 43 pharmaceutical and/or device companies across 611 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Echeverry-Franck is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 30% volume in CA $11,272 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,890
Medicare services
Top 30% in CA for endocrinology
981
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~99 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,225 $99 $204
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
209 $48 $64
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
103 $137 $264
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
50 $143 $350
Ultrasound of arm and leg arteries
A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues.
49 $80 $350
Ultrasound of leg arteries or grafts
An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present.
49 $217 $350
Ultrasound of arm or leg veins
An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers.
49 $137 $350
Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts
A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels.
49 $132 $350
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
45 $96 $195
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
33 $26 $54
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
29 $71 $143
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.6% high complexity
12.8% medium
84.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,272
Total received (2018-2024)
Avg $1,610/year across 7 years
Top 18% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
611
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,272 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,334
2023
$1,614
2022
$2,043
2021
$1,525
2020
$655
2019
$1,910
2018
$1,191

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Dexcom, Inc.
$899
Abbott Laboratories
$349
Lilly USA, LLC
$258
Bayer Healthcare Pharmaceuticals Inc.
$141
SANOFI-AVENTIS U.S. LLC
$96
Novo Nordisk Inc
$63
BETA BIONICS, INC.
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
Mannkind Corporation
$56
Tandem Diabetes Care, Inc.
$54
Amgen Inc.
$51
RECORDATI_RARE_DISEASES_INC.
$49
Xeris Pharmaceuticals, Inc.
$45
Insulet Corporation
$29
SHIELD THERAPEUTICS INC
$24
Cook Medical LLC
$20
AstraZeneca Pharmaceuticals LP
$18
Amphastar Pharmaceuticals, Inc.
$18
Medtronic, Inc.
$15
CeQur Corporation
$15
Tolmar, Inc.
$14
Top 3 companies account for 64.5% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,482
Dexcom, Inc.
$1,431
Insulet Corporation
$1,212
Novo Nordisk Inc
$795
Mannkind Corporation
$724
Abbott Laboratories
$658
SANOFI-AVENTIS U.S. LLC
$612
Boehringer Ingelheim Pharmaceuticals, Inc.
$458
MannKind Corporation
$430
Horizon Therapeutics plc
$392
Amarin Pharma Inc.
$388
Xeris Pharmaceuticals, Inc.
$320
Bayer Healthcare Pharmaceuticals Inc.
$312
IBSA Pharma Inc.
$213
AstraZeneca Pharmaceuticals LP
$195
Merck Sharp & Dohme Corporation
$187
PFIZER INC.
$150
Amgen Inc.
$123
Bayer HealthCare Pharmaceuticals Inc.
$116
Medtronic, Inc.
$101
CeQur Corporation
$90
Cook Medical LLC
$74
Becton, Dickinson and Company
$68
Corcept Therapeutics
$66
BETA BIONICS, INC.
$61
AbbVie, Inc.
$60
Tandem Diabetes Care, Inc.
$54
Bigfoot Biomedical Inc
$50
RECORDATI_RARE_DISEASES_INC.
$49
DEXCOM, INC.
$46
Novartis Pharmaceuticals Corporation
$45
Shire North American Group Inc
$41
Medtronic MiniMed, Inc.
$39
Janssen Pharmaceuticals, Inc
$37
Alvogen Inc
$31
AbbVie Inc.
$26
SHIELD THERAPEUTICS INC
$24
Antares Pharma, Inc.
$23
Intercept Pharmaceuticals, Inc.
$21
Shield Therapeutics Inc
$20
Radius Health, Inc.
$18
Amphastar Pharmaceuticals, Inc.
$18
Tolmar, Inc.
$14
Top 3 companies account for 36.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · BAQSIMI · BASAGLAR · BD Nano · BD Nano 2nd Gen Pen Needle · CeQur Simplicity · Cook Medical Beacon · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LOKELMA · LYRICA · Levemir · MINIMED 780G · MOUNJARO · Minimed 670G System · NATPARA · NOCDURNA · OCALIVA · Omnipod · Ozempic · PROCLAIM · RECORLEV · ROSEN · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITY DIABETES MANAGEMENT SYSTEM · Vascepa · Victoza · Wegovy · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Long Beach?
Compare endocrinologists in the Long Beach area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
294
Per 100K population
3.0
County median income
$87,760
Nearest hospital
MEMORIALCARE LONG BEACH MEDICAL CENTER
1.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Echeverry-Franck is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Echeverry-Franck experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Echeverry-Franck performed 1,225 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Echeverry-Franck receive payments from pharmaceutical companies?
Yes. Dr. Echeverry-Franck received a total of $11,272 from 43 companies across 611 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Echeverry-Franck's costs compare to other endocrinologists in Long Beach?
Dr. Echeverry-Franck's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Echeverry-Franck) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →